Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Malik Berhoune"'
Autor:
A. Laparra, Malik Berhoune, Christophe Massard, Cécile Cauquil, Stéphane Champiat, Benjamin Besse, Alexis Nolin-Lapalme, Caroline Robert, Christine Mateus, Charles Naltet, Frédéric Troalen, Olivier Lambotte, Stéphane Ederhy, Capucine Baldini, Aurélien Marabelle, Patricia Martin-Romano, Samia Hajem, Antoine Hollebecque, Jean-Marie Michot, P. Vuagnat
Publikováno v:
European journal of cancer (Oxford, England : 1990). 157
Aim Despite unprecedented results of anti-programmed death protein (ligand) 1 (PD-(L)1) immune checkpoint inhibitor in the oncology's armamentarium, immune-related adverse events (irAEs) represent a therapeutic hurdle. Currently, there is no consensu
Autor:
Marion Brault, Malik Berhoune, Julien Lazarovici, Vincent Ribrag, Maxime Annereau, François Lemare, Jean-Marie Michot, Capucine Baldini, Stéphane Champiat, Christophe Massard, Andrea Varga, Claude Chahine, Alina Danu
Publikováno v:
Blood. 132:2992-2992
INTRODUCTION The phase 1 selection for clinical trials of patients with relapsed or refractory Diffuse Large-B cell lymphoma (R/R DLBCL) with a potentially rapid tumor growth is a challenge. Prognostics' factors identification could help to better or
Autor:
Nicolas Martelli, Evren Sahin, Patrice Prognon, Brigitte Bonan, Malik Berhoune, Ludovic-Alexandre Vidal
Publikováno v:
Journal of Evaluation in Clinical Practice. 16:1129-1135
Rationale Due to the increase of new cancer cases, our chemotherapy compounding unit must face with ever-growing production needs. To support this increasing workload, we decided to anticipate the preparation of several anti-cancer drugs. Aims and ob
Publikováno v:
Expert Systems with Applications
Expert Systems with Applications, Elsevier, 2010, 37 (2), pp.1528-1534. ⟨10.1016/j.eswa.2009.06.067⟩
Expert Systems with Applications, Elsevier, 2010, 37 (2), pp.1528-1534. ⟨10.1016/j.eswa.2009.06.067⟩
This paper focuses on the application of the analytical hierarchy process (AHP) technique in the context of production and distribution of anti cancer drugs within the pharmacy department of a French hospital. This is achieved by evaluating how AHP c
Autor:
Salvatore Cisternino, Audrey Toledano, Clémence Godard, Malik Berhoune, Joël Schlatter, Fouad Chiadmi, Eric Bertrand, Jean-Eudes Fontan
Publikováno v:
La Presse Médicale. 37:477-484
Postpartum hemorrhage is defined by bleeding > 500 mL through the vagina. It is one of the obstetrical complications that obstetricians fear most. It is the leading cause of maternal mortality in the world, especially in developing countries. The ref
Autor:
Brigitte, Bonan, Nicolas, Martelli, Malik, Berhoune, Ludovic-Alexandre, Vidal, Evren, Sahin, Patrice, Prognon
Publikováno v:
Journal of evaluation in clinical practice. 16(6)
Due to the increase of new cancer cases, our chemotherapy compounding unit must face with ever-growing production needs. To support this increasing workload, we decided to anticipate the preparation of several anti-cancer drugs.To help us in the deci
Autor:
Malik Berhoune, Audrey Junker, Agnes Bellanger, Clotilde Moussay, Marie-Catherine Desroches, Robert Farinotti, Sandrine Roy, Christine Fernandez
Publikováno v:
The Annals of pharmacotherapy. 43(2)
Autor:
Clémence, Godard, Malik, Berhoune, Eric, Bertrand, Joël, Schlatter, Fouad, Chiadmi, Audrey, Toledano, Salvatore, Cisternino, Jean-Eudes, Fontan
Publikováno v:
Presse medicale (Paris, France : 1983). 37(3 Pt 2)
Postpartum hemorrhage is defined by bleeding500 mL through the vagina. It is one of the obstetrical complications that obstetricians fear most. It is the leading cause of maternal mortality in the world, especially in developing countries. The refere
Autor:
Patrice Prognon, Brigitte Bonan, Jean-Pierre Grandhaye, Corinne Dayot, Hail Aboudagga, Aude Jacob, Malik Berhoune
Publikováno v:
American Journal of Health-System Pharmacy. 68:557-558
Centralized cancer chemotherapy compounding in the pharmacy and computerized order entry for each step of the chemotherapy cycle are now mandatory in France. Centralized preparation of cancer chemotherapy presents two major advantages: (1) safer ther
Autor:
Brigitte Bonan, Malik Berhoune, Hail Aboudagga, J. Stevens, Stéphane Oudard, Scotte Florian, Patrice Prognon, Fouque Julien, Ludovic Tripault
Publikováno v:
BMJ Quality & Safety. 19:A61-A62
Context, purpose The increased number of patients treated in outpatient medical oncology units impacts significantly on the number of chemotherapy compoundings delivered by the pharmacy department. A pilot project (PROCHE: Chemotherapies Optimisation